Aristarchus, you would be closer to the money if you worked on SPL receiving a 20 to 25% royalty on sales and l for one don't think gross revenue of $1.75 billion will ever be achieved. Jackie has always been keen on throwing big numbers around. She's been doing it for years.
So to be conservative lets say $500 million p.a @ 20% royalty income gives $100 million p.a. income which may be achieved in 2019/20 f.y.
No doubt operating costs will increase as with additional cash flow they will be able to throw more at R&D of which l guarantee they will. Make expenses $35m which leaves $65m net profit or .18c/share. As they have abundant "blue sky" l would work on a PE of at least 20:1 which gives a minimum share price of $3.60 based on revenue from BV alone.
Add in the DEP program and Vivagel for other applications will add some more value given positive DEP trial results which is almost a certainty and maybe we are looking at $5.
So as l said the other day How long is a piece of string? Well at least this long l reckon.
SPL Price at posting:
$1.04 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)